The Europe CRO Market is accelerating pharmaceutical development providing comprehensive clinical trial services through IQVIA Europe, LabCorp Europe, PPD, and other CROs reducing drug development timelines by 30%, lowering costs by 20%, and improving trial success rates to 85% enabling European pharmaceutical companies to bring new treatments to patients faster while maintaining...

The India CRO Market is transforming pharmaceutical development providing comprehensive clinical trial services through Quark, Elicious, IQVIA India, and other CROs reducing drug development timelines by 35%, lowering costs by 45-55%, and improving trial success rates to 82% enabling Indian pharmaceutical companies to bring new treatments to patients faster while maintaining quality...